199 related articles for article (PubMed ID: 26998870)
21. In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma.
Kurakula M; Naveen NR
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32283782
[TBL] [Abstract][Full Text] [Related]
22. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium.
Hiwale P; Lampis S; Conti G; Caddeo C; Murgia S; Fadda AM; Monduzzi M
Biomacromolecules; 2011 Sep; 12(9):3186-93. PubMed ID: 21809827
[TBL] [Abstract][Full Text] [Related]
23. Preparation of collagen/hydroxyapatite/alendronate hybrid hydrogels as potential scaffolds for bone regeneration.
Ma X; He Z; Han F; Zhong Z; Chen L; Li B
Colloids Surf B Biointerfaces; 2016 Jul; 143():81-87. PubMed ID: 26998869
[TBL] [Abstract][Full Text] [Related]
24. Encapsulated boron as an osteoinductive agent for bone scaffolds.
Gümüşderelioğlu M; Tunçay EÖ; Kaynak G; Demirtaş TT; Aydın ST; Hakkı SS
J Trace Elem Med Biol; 2015; 31():120-8. PubMed ID: 26004902
[TBL] [Abstract][Full Text] [Related]
25. Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations.
Jafari S; Maleki-Dizaji N; Barar J; Barzegar-Jalali M; Rameshrad M; Adibkia K
Eur J Pharm Sci; 2016 Aug; 91():225-35. PubMed ID: 27189528
[TBL] [Abstract][Full Text] [Related]
26. A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging.
Ranjan AP; Zeglam K; Mukerjee A; Thamake S; Vishwanatha JK
Nanotechnology; 2011 Jul; 22(29):295104. PubMed ID: 21693801
[TBL] [Abstract][Full Text] [Related]
27. [Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].
Li XY; Zhu ZJ; Cheng AY
Yao Xue Xue Bao; 2008 Feb; 43(2):208-13. PubMed ID: 18507351
[TBL] [Abstract][Full Text] [Related]
28. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
29. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
[TBL] [Abstract][Full Text] [Related]
30. Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery.
Gugleva V; Titeva S; Ermenlieva N; Tsibranska S; Tcholakova S; Rangelov S; Momekova D
Int J Pharm; 2020 Dec; 591():120010. PubMed ID: 33132152
[TBL] [Abstract][Full Text] [Related]
31. Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation.
Shan-Bin G; Yue T; Ling-Yan J
Drug Dev Ind Pharm; 2015 Apr; 41(4):573-82. PubMed ID: 24502270
[TBL] [Abstract][Full Text] [Related]
32. Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery.
Dukovski BJ; Plantić I; Čunčić I; Krtalić I; Juretić M; Pepić I; Lovrić J; Hafner A
Int J Pharm; 2017 Nov; 533(2):480-487. PubMed ID: 28577969
[TBL] [Abstract][Full Text] [Related]
33. Sol-gel transition of nanoparticles/polymer mixtures for sustained delivery of exenatide to treat type 2 diabetes mellitus.
Oh KS; Kim JY; Yoon BD; Lee M; Kim H; Kim M; Seo JH; Yuk SH
Eur J Pharm Biopharm; 2014 Nov; 88(3):664-9. PubMed ID: 25152212
[TBL] [Abstract][Full Text] [Related]
34. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model.
Hafner A; Lovrić J; Romić MD; Juretić M; Pepić I; Cetina-Čižmek B; Filipović-Grčić J
Eur J Pharm Sci; 2015 Jul; 75():142-50. PubMed ID: 25869457
[TBL] [Abstract][Full Text] [Related]
36. Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.
Ju C; Sun J; Zi P; Jin X; Zhang C
J Pharm Sci; 2013 Aug; 102(8):2707-17. PubMed ID: 23839931
[TBL] [Abstract][Full Text] [Related]
37. Controlled SLN Delivery by Thermoresponsive In-situ Forming Erodible Gels; A Whole-body and Organ Imaging Study.
Dorraj G; Dadashzadeh S; Erfan M; Moghimi HR
Curr Drug Deliv; 2018; 15(4):510-519. PubMed ID: 29422000
[TBL] [Abstract][Full Text] [Related]
38. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
39. Colorectal distribution and retention of polymeric nanoparticles following incorporation into a thermosensitive enema.
Melo M; Nunes R; Sarmento B; das Neves J
Biomater Sci; 2019 Sep; 7(9):3801-3811. PubMed ID: 31237275
[TBL] [Abstract][Full Text] [Related]
40. Development of drug-loaded chitosan-vanillin nanoparticles and its cytotoxicity against HT-29 cells.
Li PW; Wang G; Yang ZM; Duan W; Peng Z; Kong LX; Wang QH
Drug Deliv; 2016; 23(1):30-5. PubMed ID: 24712731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
